Thank you for your analysis , IMHO the market look at CHM with confusion , the reasons you point out above shows there should be "Considerable Value here" but the SP and MC is pocket change in the greater scheme of things,, Market awareness was poor under the previous CEO,,for years.. Rebecca is doing everything with in her power to bring CHM to the surface but the last CR and the delivery of Positive data ,,Complete Response was made during suspension so no mileage was gained ,, the SP erosion down from 3.6c to 1.4c was in silence from Management then Hopper and Sophs purchased at .008 with a free option so really .004c ,, possibly a consolidation could change perception as when you see the visual of the SP at .006c it seems to devalue the Science ,, if it was a 10:1 the SP would at least look like there is Value at 6c...
Must say Rebecca has responded to all emails and she is pushing for CHM recognition ,,,, The critical issue is Investors "Invest" for a return on Capital and everyone who holds CHM is financially underwater...
Positive Scientific Data is what will move the needle but will the BOD just smash another CR again?
I have a truckload of this stock , usually I would average down but until Management can show a clear strategy to even recoup lost Investor Value my finger wont be hovering over the Buy Button.. NZT
Add to My Watchlist
What is My Watchlist?
